 empir therapi amphotericin febril granulocytopen patient earli diagnosi invas fungal infect granulocytopen patient unreli granulocytopen patient febril therapi appropri antibacteri agent high risk develop infect random clinic trial empir administr amphotericin febril granulocytopen patient frequenc morbid mortal invas fungal infect effect granulocytopen patient antifung prophylaxi current studi prompt empir administr amphotericin febril granulocytopen patient treatment deep mycos role antifung triazol compound liposom lipid complex amphotericin empir antifung therapi clinic trial